DirectTrust has acquired the assets of SAFE Identity, formerly known as SAFE-BioPharma, as a means to strengthen our identity assurance capabilities and further enable the interoperable flow of health data.
SAFE Identity and DirectTrust are both vibrant consensus-driven PKI-based trust communities with complementary missions:
- DirectTrust enables assurance in security and trust in identity for health information exchange
- SAFE Identity enables the security and identity assurance for pharmaceutical companies and the federal agencies they need to connect to
Instilling trust in interoperable exchange starts with identity – confidently knowing and trusting the identity of a person, organization, or device. Trust Frameworks provide the structure and foundation, including identity verification, to enable interoperability at scale.
Incorporating SAFE Identity’s assets and Trust Framework into DirectTrust allows the opportunity to advance trusted communication and identity, strengthen our PKI competency, diversify to new use cases and possibilities, as well as enable trusted exchange in new contexts and sectors.
Read on to learn more about DirectTrust Identity and Trust Frameworks, or check out our Frequently Asked Questions.